These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 29744599)
1. Endovascular Baroreflex Amplification for Resistant Hypertension. van Kleef MEAM; Bates MC; Spiering W Curr Hypertens Rep; 2018 May; 20(5):46. PubMed ID: 29744599 [TBL] [Abstract][Full Text] [Related]
2. Baroreflex Amplification and Carotid Body Modulation for the Treatment of Resistant Hypertension. Groenland EH; Spiering W Curr Hypertens Rep; 2020 Mar; 22(4):27. PubMed ID: 32166464 [TBL] [Abstract][Full Text] [Related]
3. Baroreflex stimulation for treating resistant hypertension: ready for the prime-time? Bolignano D; Coppolino G Rev Cardiovasc Med; 2018 Sep; 19(3):89-95. PubMed ID: 31054557 [TBL] [Abstract][Full Text] [Related]
4. Electrical carotid baroreceptor stimulation. Schmidli J; von Allmen RS; Mohaupt MG Wien Med Wochenschr; 2014 Dec; 164(23-24):508-14. PubMed ID: 25411011 [TBL] [Abstract][Full Text] [Related]
5. The pathophysiological basis of carotid baroreceptor stimulation for the treatment of resistant hypertension. Lovic D; Manolis AJ; Lovic B; Stojanov V; Lovic M; Pittaras A; Jakovljevic B Curr Vasc Pharmacol; 2014 Jan; 12(1):16-22. PubMed ID: 23905596 [TBL] [Abstract][Full Text] [Related]
14. Carotid baroreceptor activation for the treatment of resistant hypertension and heart failure. Doumas M; Faselis C; Tsioufis C; Papademetriou V Curr Hypertens Rep; 2012 Jun; 14(3):238-46. PubMed ID: 22457242 [TBL] [Abstract][Full Text] [Related]
15. Baroreceptors in the carotid and hypertension-systematic review and meta-analysis of the effects of baroreflex activation therapy on blood pressure. Wallbach M; Koziolek MJ Nephrol Dial Transplant; 2018 Sep; 33(9):1485-1493. PubMed ID: 29136223 [TBL] [Abstract][Full Text] [Related]
16. Electrical carotid sinus stimulation in treatment resistant arterial hypertension. Jordan J; Heusser K; Brinkmann J; Tank J Auton Neurosci; 2012 Dec; 172(1-2):31-6. PubMed ID: 23146623 [TBL] [Abstract][Full Text] [Related]
17. [Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection : Recommendations of the BAT consensus group 2017]. Koziolek M; Beige J; Wallbach M; Zenker D; Henning G; Halbach M; Mader N; Mahfoud F; Schlieper G; Schwenger V; Hausberg M; Börgel J; Lodde M; van der Giet M; Müller-Ehmsen J; Passauer J; Parmentier S; Lüders S; Krämer BK; Büttner S; Limbourg F; Jordan J; Vonend O; Predel HG; Reuter H Internist (Berl); 2017 Oct; 58(10):1114-1123. PubMed ID: 28835975 [TBL] [Abstract][Full Text] [Related]
19. Device profile of the MobiusHD EVBA system for the treatment of resistant hypertension: overview of its mechanism of action, safety and efficacy. Bates MC; Stone GW; Chen CY; Spiering W Expert Rev Med Devices; 2020 Jul; 17(7):649-658. PubMed ID: 32510250 [TBL] [Abstract][Full Text] [Related]